Beneficiality of combined levetiracetam, clonazepam for myoclonus in MERRF requires further confirmation
Main Authors: | Josef Finsterer, Peng Lyu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2019-03-01
|
Series: | Chinese Medical Journal |
Online Access: | http://journals.lww.com/10.1097/CM9.0000000000000042 |
Similar Items
-
Diagnosing MERRF requires clinical and genetic evidence
by: Josef Finsterer
Published: (2020-10-01) -
Stimulus-induced myoclonus treated effectively with clonazepam in genetically confirmed Coffin–Lowry syndrome
by: Elif Acar Arslan, et al.
Published: (2014-01-01) -
Photosensitive Epilepsy and Polycystic Ovary Syndrome as Manifestations of MERRF
by: Josef Finsterer
Published: (2020-01-01) -
Suppression of Myoclonus in Corticobasal Degeneration by Levetiracetam
by: Jae Wook Cho, et al.
Published: (2014-04-01) -
When should MERRF (myoclonus epilepsy associated with ragged-red fibers) be the diagnosis?
by: Paulo José Lorenzoni, et al.
Published: (2014-10-01)